← Back to Clinical Trials
Recruiting NCT05629104

NCT05629104 Prediction of Long-term Outcome in Aortic Stenosis After Valve Intervention

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05629104
Status Recruiting
Phase
Sponsor Uppsala University
Condition Aortic Stenosis
Study Type OBSERVATIONAL
Enrollment 300 participants
Start Date 2019-05-15
Primary Completion 2024-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
There is no intervention since it is an observational study patients are treated according to clinical praxis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 300 participants in total. It began in 2019-05-15 with a primary completion date of 2024-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Patients with severe aortic stenosis accepted for transcatheter intervention or open surgery are included before the intervention, and then followed up with clinical visits during the first year after intervention. Imaging with echocardiography and computed tomography (CT) are performed together with additional imaging with magnetic resonance imaging (MRI) and Positron emissions tomography (PET)-CT in a subgroup of the study population. Blood samples, physical performance and questionnaires with focus on frailty and heart failure are also collected at each visit. A follow up with information of the outcomes after 2-5 years will be performed through national registries.

Eligibility Criteria

Inclusion Criteria: * Accepted for aortic valve intervention Exclusion Criteria: * No able to follow the study protocol

Contact & Investigator

Central Contact

Christina Christersson, MD PhD

✉ christina.christersson@medsci.uu.se

📞 +46186119068

Principal Investigator

Christina Christersson, MD PhD

PRINCIPAL INVESTIGATOR

VO hjärt-lungmedicin och klinisk fysiologi Akademiska Sjukhuset

Frequently Asked Questions

Who can join the NCT05629104 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Aortic Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05629104 currently recruiting?

Yes, NCT05629104 is actively recruiting participants. Contact the research team at christina.christersson@medsci.uu.se for enrollment information.

Where is the NCT05629104 trial being conducted?

This trial is being conducted at Uppsala, Sweden.

Who is sponsoring the NCT05629104 clinical trial?

NCT05629104 is sponsored by Uppsala University. The principal investigator is Christina Christersson, MD PhD at VO hjärt-lungmedicin och klinisk fysiologi Akademiska Sjukhuset. The trial plans to enroll 300 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology